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Introduction
Heterotopic ossification (HO) is a benign process by
which trabecular bone forms outside of the skeletal
structure, occupying space in soft tissue where it does
not normally exist. HO has been recognised to occur in
three distinct contexts: trauma, neurological injury and
genetic abnormalities. Traumatic HO typically follows
fractures, dislocations, operative procedures, and
severe burns, most commonly seen around the hip
followed by elbow and shoulder joints after fracture
and open reduction-internal fixation (ORIF) procedures
or arthroplasties.1,2 The pathogenesis of HO is unclear,
but may involve inappropriate differentiation of
pluripotent mesenchymal cells into bone-forming cells
under the influence ofinductive stimuli in a permissive
environment.1-3
The incidence of HO around elbow joint is estimated to
be 3% after local trauma or dislocation4 and increases
up to 15-50% when dislocation is combined with
fracture, and to >50% in fractures involving the radial
head.4 The incidence of HO in patients undergoing
acetabular fracture fixation varies depending upon
what approach is used, associated injuries, open
fracture and can be as high 90%.2,5-7 Unfortunately, HO
is detectable on radiographs as late as 4-12 weeks after
injury when no efficient therapy is available. Almost
30% of all patients presenting with HO will develop
symptoms, including pain and restricted motion that
may require secondary surgical procedures.8 Surgical
excision is the treatment of choice for pre-existing HO,
but recurrence rates can be as high as 80-
100%.Therefore, prophylaxis with radiotherapy (RT) or
non-steroidal anti-inflammatory drugs (NSAIDS) is the
mainstay of treatment. The effectiveness of both
prophylactic therapies has been extensively studied,
but no conclusive data exists to indicate superiority of
one treatment modality over the other.1-3,9
The current study was planned to review experience of
using RT and NSAIDS in the prevention of HO after ORIF
for fractures around hip and elbow joints.
Patients and Methods
The retrospective chart review was conducted at the
Aga Khan University Hospital and comprised record of
patients who underwent ORIF for elbow and acetabular
fractures between 2009 and 2013. Data was classified
into three groups: Group A patients had received single
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Abstract
Objective: To compare the efficacy and safety of prophylactic modalities for heterotopic ossification prevention
after elbow and acetabular surgeries.
Methods: The retrospective chart review was conducted at the Aga Khan University Hospital and comprised record
of patients who underwent open reduction and internal fixation for elbow and acetabular fractures between 2010
and 2013. Data was classified into three groups: Group A patients had received single dose of radiotherapy; Group
B patients had received indomethacin, and Group C patients had not received any prophylaxis. Outcome variables
included time-to-fracture healing, heterotopic ossification, non-union and wound infection.
Results: Of the 104patients 70(67.3%) had elbow fractures and 34(32.7%) had acetabular fractures. Out of the
70patients with elbow fractures, 28(27%) were in Group A, 24(23%) in Group B, and 18(17%) in Group C. In Group A,
4(22%) patients had wound infection compared to 1(5.5%) patient in Group C (p=0.131). One (4%) patient in Group
B and 1(5.5%) in Group C developed heterotopic ossification (p=0.486). Non-union occurred in 1(4%) patient in
Group B and 1(5.5%) in Group C. Out of the 34 patients with acetabular fractures, 11(32.3%) were in Group A,
10(29.4%) in Group B, and 13(38.2%) in Group C. In Group A, 2(18.2%) patients developed wound infection. Only
1(7.6%) patient in Group C developed heterotopic ossification.
Conclusion: No role of radiotherapy or indomethacin was detected in the prevention of heterotopic ossification.
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dose of RT within 24 hours of fracture fixation at a dose
of 7Gy; Group B patients had received indomethacin
25mg 3 times a day for 3 weeks, and Group C patients
had not received any prophylaxis. The decision of
prophylactic modality was based on surgeon's
preference. Outcome variables included time-to-
fracture healing, HO in terms of radiological and
functional failure rates, non-union and wound infection.
The presence of HO was diagnosed both clinically by
assessment of the range of movement and
radiologically by X-rays. Radiographs were taken at 1.5,
3, 6 and 12 months post-operatively. These films were
reviewed by two independent radiologists who were
blinded to the method of treatment. In patients with
elbow and acetabular fractures, the extent of HO was
assessed with and Graham classification10 and Brooker
grading system11 respectively. All the patients had a
minimum of 12-month follow-up, ranging from 13 to 25
months.
SPSS 20 was used for data analysis. Chi square was used
for categorical variables and t test for continuous
variables. P<0.05 was considered statistically
significant.
Results
Of the 104patients, 70(67.3%) had elbow fractures and
34(32.7%) had acetabular fractures. Overall mean age
was 44.62±17.31 years. All the fractures were close
(100%) and the three groups did not differ statistically
in terms of age, gender and injury-to-operation time
(p>0.05 each) between the groups.
Out of the 70 patients with elbow fractures, 28(27%)
were in Group A, 24(23%) in Group B, and 18(17%) in
Group C. In Group A, 4(22%) patients had wound
infection compared to 1(5.5%) patient in Group C
(p=0.131). One (4%) patient in Group B and 1(5.5%) in
Group C developed HO (p=0.486) (Table-1). The lone
Group C patient developed grade III HO with significant
functional limitation requiring surgical management.
Non-union occurred in 1(4%) patient in Group B and
1(5.5%) in Group C.
Out of the 34 patients with acetabular fractures,
11(32.3%) were in Group A, 10(29.4%) in Group B, and
13(38.2%) in Group C. In Group A, 2(18.2%) patients
developed wound infection. Only 1(7.6%) patient in
Group C developed HO requiring surgical excision
(Table-2).
Two (6%) patients had non-union at fracture site and
underwent revision surgery with bone grafting.
Mean time to fracture healing was comparable among
the groups (p>0.05).
The full treatment protocol was not completed in 3(9%)
Group B patients due to noncompliance, and 1(33%) of
them developed HO. Group B patients encountered
gastrointestinal disturbances but bot significant
enough to warrant discontinuation of treatment.
Discussion
The study failed to demonstrate the role of RT or NSAIDs
in the prevention of HO after ORIF for elbow and
acetabular fractures. However, these modalities
continue to be used widely for HO prevention. The
effectiveness of RT is attributed to the radio-sensitivity
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Table-1: Outcomes in patients with elbow fractures.
Groups No. of patients HO Wound infection Non-union Time to fracture healing (months)
A 28 0 4 0 3.5
B 24 1 0 1 4.5
C 18 1 1 1 4
p-value 0.486 0.131 0.486 0.263
HO: Heterotopic ossification.
Table-2: Outcomes in patients with hip fractures.
Groups No. of patients HO Wound infection Non-union Time to fracture healing (months)
A 11 0 4 0 4
B 10 0 0 0 4.5
C 13 1 1 0 4
P-value 0.435 0.29 0.565
HO: Heterotopic ossification.
of the osteoprogenitor cells present in the early phase
of HO development.2,3 Indomethacin works by
inhibiting prostaglandin (PG)-mediated (specifically
PGE-2) bone remodelling and also by directly inhibiting
the differentiation of osteoprogenitorcells.3,12,13
A meta-analysis1 of seven randomised studies (1,143
patients) comparing RT with NSAIDs for HO prophylaxis
in patients undergoing ORIF for acetabular fracture or
total hip arthroplasty (THA) demonstrated RT to be
more effective than NSAIDs in preventing clinically
significant (Brooker Grade 3 or 4) HO (risk ratio = 0.42;
95% CI = 0.18-0.97). The timing of administration is
important since the success rate decreases from 98% to
33% after the fourth post-operative day.14
The effectiveness of indomethacin in HO prevention
was compared with that of radiation in a prospective,
randomised trial.13 which concluded that there is no
difference in the rates of HO according to prevention
modality. It also noted a significant increase in long
bone non-union in patients receiving indomethacin
compared to RT (26% vs. 7%; p=0.004). In a study,15 142
patients were followed for formation of HO following
THA. Of the 11 that underwent a revision procedure
secondary to aseptic loosening, 10 belonged to the
indomethacin group. Moreover, prolonged use of
NSAIDs is associated with gastrointestinal side effects,
such as gastritis and ulcer formation. Finally, there are
issues of patient compliance with prolonged duration
of treatment.2,15
However, the use of RT is not free of drawbacks.
Potential risks of RT include malignancy, impaired
healing, infertility, genetic alteration and there is the
issue of availability of RT and its higher cost compared
to indomethacin.2,3 In a review of their 50-year
experience of radiation-induced sarcomas, Kim et al16
reported no cases of bone or soft-tissue sarcomas in
patients exposed to doses lower than 30Gy. A
randomised controlled trial9 found no significant
differences between the RT and control groups with
regard to the prevalence of HO, and post-operative
range of motion (ROM). However, the non-union rate in
the RT group was exceptionally high 38%which led to
early termination of the study.
Since the development and use of NSAIDs and RT for
HO prophylaxis, there have been several studies
attempting to pinpoint new aspects of HO aetiology
and thus direct the development of new prophylactic
modalities with increased efficacy and fewer side
effects.4,12 Local use of Noggin,12 pulsed
electromagnetic fields (PEMF) and free radical
scavengers such as allopurinol and N-acetyl cysteine12
have shown promising results inpreventing ectopic
bone formation.
The debate continues as to which modality is the best
one for the prevention of HO. However, the issues are
different from a developing nation's perspective where
the debate still moves around the most cost-effective
method of treatment. In a healthcare system with
inequitable distribution of medical facilities where
patients themselves are primary payers of medicare
services, radiotherapy is an expensive option. Therefore,
treatment of this benign and preventable condition has
also become challenging.
In terms of limitations, the retrospective nature and
small sample size of the study, its findings cannot be
generalised regarding the rationale for choosing
prophylaxis modality in individual cases.
Conclusion
There was no role of RT or NSAIDs in the prevention of
HO. Decision should be based on patient's co-
morbidities, cost, availability of RT, and anticipated
compliance with the treatment plan.
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